CEO: Jonathan Hunt
Revenue: Rs 1,113 crore
The global healthcare CRO market is expected reach $45 billion by 2022, according to report by Grand View Resarech. The global CRO market expected to grow at a CAGR of more than 6 percent over the next seven years. According to a report, increasing R&D spend, M&A, outsourcing, patent expirations & government organizations are assigning projects to CROs.
In 2015, Bengaluru-based CRO Syngene International's starry IPO debut took the whole industry by storm.